EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 40 / No 10 (Octobre 2024) Med Sci (Paris), 40 10 (2024) 789-791 References
Issue
Med Sci (Paris)
Volume 40, Number 10, Octobre 2024
Chroniques génomiques
Page(s) 789 - 791
Section Forum
DOI https://doi.org/10.1051/medsci/2024107
Published online 25 October 2024
  1. Medina JE, Dracopoli NC, Bach PB, et al. Cell-free DNA approaches for cancer early detection and interception. J Immunother Cancer 2023 ; 11 : e006013. [CrossRef] [PubMed] [Google Scholar]
  2. Jordan B. Le Graal de Grail est-il un mirage ? Med Sci (Paris) 2016 ; 32 : 417–20. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  3. Jordan B. Le dépistage du cancer sauve-t-il vraiment des vies ? Med Sci (Paris) 2023 ; 39 : 885–7. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  4. Liu MC, Oxnard GR, Klein EA, et al. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann Oncol 2020 ; 31 : 745–59. [CrossRef] [PubMed] [Google Scholar]
  5. Klein EA, Richards D, Cohn A, et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann Oncol 2021 ; 32 : 1167–77. [CrossRef] [PubMed] [Google Scholar]
  6. Esserman LJ, Thompson IM, Reid B, et al. Addressing overdiagnosis and overtreatment in cancer: a prescription for change. Lancet Oncol 2014 ; 15 : e234–42. [CrossRef] [PubMed] [Google Scholar]
  7. Turnbull C, Firth HV, Wilkie AOM, et al. Population screening requires robust evidence-genomics is no exception. Lancet 2024 ; 403 : 583–6. [CrossRef] [PubMed] [Google Scholar]
  8. NHS to pilot potentially revolutionary blood test that detects more than 50 cancers. www.england.nhs.uk/2020/11/nhs-to-pilot-potentially-revolutionary-blood-test/ [Google Scholar]
  9. Old R, Pharoah P, Wald N. NHS announces a pilot of a blood test for early detection of many cancers. J Med Screen 2021 ; 28 : 1–2. [CrossRef] [PubMed] [Google Scholar]
  10. Turnbull C, Wald N, Sullivan R, et al. GRAIL-Galleri: why the special treatment? Lancet 2024 ; 403 : 431–2. [CrossRef] [PubMed] [Google Scholar]
  11. Johnson P. Response to GRAIL-Galleri: why the special treatment? Lancet 2024 ; 403 : 432–3 [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.